LBF20207TX02 - Revision history

Editor at 00:00, 17 January 2014

2014-01-17T00:00:00Z

@@ Line 19: / Line 19: @@
 |Symbol=TXB2
 |Biological Activity=Thromboxane B2 as s stable degradation product of thromboxane A2 shows diminishd biological activity [[Reference:Whittle_BJ:Moncada_S:,Br. Med. Bull.,1983,39,232|{{RelationTable/GetFirstAuthor|Reference:Whittle_BJ:Moncada_S:,Br. Med. Bull.,1983,39,232}}]].
 }}
 {{Lipid/Footer}}

Editor at 07:04, 21 October 2010

2010-10-21T07:04:49Z

← Older revision		Revision as of 16:04, 21 October 2010
Line 6:		Line 6:
	\|LipidBank=XPR2101		\|LipidBank=XPR2101
	\|LipidMaps=LMFA03030002		\|LipidMaps=LMFA03030002
	\|SysName=7- [ Tetrahydro-4 (S) ,6-dihydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -2H-pyran-3 (S) -yl ] -5 (Z) -heptenoic acid		\|SysName=7- [Tetrahydro- (4S,6) -dihydroxy-2 R- (3S-hydroxy-trans-1-octenyl) -2H-pyran-3S-yl] -cis-5-heptenoic acid
	~~\|Common Name=&&THROMBOXANE B2~~&&		\|Common Name=&&Thromboxane B2&&7- [ Tetrahydro-4 (S) ,6-dihydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -2H-pyran-3 (S) -yl ] -5 (Z) -heptenoic acid&&
	\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|Optical=[ alpha ]^{25}_D =57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Optical=[ alpha ]^{25}_D =57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]

Dbmanager at 02:02, 8 September 2010

2010-09-08T02:02:45Z

← Older revision		Revision as of 11:02, 8 September 2010
Line 9:		Line 9:
	\|Common Name=&&THROMBOXANE B2&&		\|Common Name=&&THROMBOXANE B2&&
	\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|Optical=[ alpha ]X^{25}_D =57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Optical=[ alpha ]^{25}_D =57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|Solubility=ETHYL ACETATE [[Reference:Kelly RW:Schletter_I:Stein_SJ:,Tetrahedron_Lett.,1976,,3279\|{{RelationTable/GetFirstAuthor\|Reference:Kelly RW:Schletter_I:Stein_SJ:,Tetrahedron_Lett.,1976,,3279}}]]		\|Solubility=ETHYL ACETATE [[Reference:Kelly RW:Schletter_I:Stein_SJ:,Tetrahedron_Lett.,1976,,3279\|{{RelationTable/GetFirstAuthor\|Reference:Kelly RW:Schletter_I:Stein_SJ:,Tetrahedron_Lett.,1976,,3279}}]]
	\|Mass Spectra=m/e 335, 317 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Mass Spectra=m/e 335, 317 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]

Editor at 09:14, 9 June 2010

2010-06-09T09:14:38Z

← Older revision		Revision as of 18:14, 9 June 2010
Line 10:		Line 10:
	\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|Optical=[ alpha ]X^{25}_D =57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Optical=[ alpha ]X^{25}_D =57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|Solubility=ETHYL ACETATE [[Reference:Kelly RW:Schletter_I:Stein_SJ:,Tetrahedron_Lett.,1976,,3279\|{{RelationTable/GetFirstAuthor\|~~RReference~~:Kelly RW:Schletter_I:Stein_SJ:,Tetrahedron_Lett.,1976,,3279}}]]		\|Solubility=ETHYL ACETATE [[Reference:Kelly RW:Schletter_I:Stein_SJ:,Tetrahedron_Lett.,1976,,3279\|{{RelationTable/GetFirstAuthor\|Reference:Kelly RW:Schletter_I:Stein_SJ:,Tetrahedron_Lett.,1976,,3279}}]]
	\|Mass Spectra=m/e 335, 317 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Mass Spectra=m/e 335, 317 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|IR Spectra=FILM: nu 3380, 1705cm^{-1} [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|IR Spectra=FILM: nu 3380, 1705cm^{-1} [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]

Editor at 09:14, 9 June 2010

2010-06-09T09:14:09Z

← Older revision		Revision as of 18:14, 9 June 2010
Line 10:		Line 10:
	\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|Optical=[ alpha ]X^{25}_D =57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Optical=[ alpha ]X^{25}_D =57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|Solubility=ETHYL ACETATE		\|Solubility=ETHYL ACETATE [[Reference:Kelly RW:Schletter_I:Stein_SJ:,Tetrahedron_Lett.,1976,,3279\|{{RelationTable/GetFirstAuthor\|RReference:Kelly RW:Schletter_I:Stein_SJ:,Tetrahedron_Lett.,1976,,3279}}]]
	\|Mass Spectra=m/e 335, 317 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Mass Spectra=m/e 335, 317 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|IR Spectra=FILM: nu 3380, 1705cm^{-1} [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|IR Spectra=FILM: nu 3380, 1705cm^{-1} [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]

Editor: LBF20307TX02 moved to LBF20207TX02

2010-04-14T21:00:00Z

LBF20307TX02 moved to LBF20207TX02

← Older revision		Revision as of 06:00, 15 April 2010
Line 7:		Line 7:
	\|LipidMaps=LMFA03030002		\|LipidMaps=LMFA03030002
	\|SysName=7- [ Tetrahydro-4 (S) ,6-dihydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -2H-pyran-3 (S) -yl ] -5 (Z) -heptenoic acid		\|SysName=7- [ Tetrahydro-4 (S) ,6-dihydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -2H-pyran-3 (S) -yl ] -5 (Z) -heptenoic acid
	\|Common Name=&&THROMBOXANE B2~~&&7- [ Tetrahydro-4 (S) ,6-dihydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -2H-pyran-3 (S) -yl ] -5 (Z) -heptenoic acid~~&&		\|Common Name=&&THROMBOXANE B2&&
	\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|Optical=[ alpha ]X^{25}_D =57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Optical=[ alpha ]X^{25}_D =57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]

Editor: LBF20307TX02 moved to LBF20207TX02

2010-02-25T10:00:10Z

LBF20307TX02 moved to LBF20207TX02

← Older revision		Revision as of 19:00, 25 February 2010
Line 9:		Line 9:
	\|Common Name=&&THROMBOXANE B2&&7- [ Tetrahydro-4 (S) ,6-dihydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -2H-pyran-3 (S) -yl ] -5 (Z) -heptenoic acid&&		\|Common Name=&&THROMBOXANE B2&&7- [ Tetrahydro-4 (S) ,6-dihydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -2H-pyran-3 (S) -yl ] -5 (Z) -heptenoic acid&&
	\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|Optical=[ alpha ]X^~~25_D~~ =57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Optical=[ alpha ]X^{25}_D =57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|Solubility=ETHYL ACETATE		\|Solubility=ETHYL ACETATE
	\|Mass Spectra=m/e 335, 317 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Mass Spectra=m/e 335, 317 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|IR Spectra=FILM: nu 3380, 1705cm^- ^1 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|IR Spectra=FILM: nu 3380, 1705cm^{-1} [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|NMR Spectra=^1 H-NMR(CDCl_3 ) : delta 5.86(m, 1H, 14-CH), 5.72(m, 1H, 13-CH), 5.46(m, 2H, 5,6-CH), 5.35 and 5.23(m, 1H, 11-CH), 4.41(m, 1H, 12-CH), 4.22(m, 1H, 15-CH), 4.11(m, 1H, 9-CH), 2.35(t, 2H, 2-CH_2 ), 0.89(m, 3H, 20-CH_3 ) [[Reference:Kotovych_G:Aarts_GHM:,Can. J. Chem.,1980,58,1111\|{{RelationTable/GetFirstAuthor\|Reference:Kotovych_G:Aarts_GHM:,Can. J. Chem.,1980,58,1111}}]]		\|NMR Spectra=^1 H-NMR(CDCl_3 ) : delta 5.86(m, 1H, 14-CH), 5.72(m, 1H, 13-CH), 5.46(m, 2H, 5,6-CH), 5.35 and 5.23(m, 1H, 11-CH), 4.41(m, 1H, 12-CH), 4.22(m, 1H, 15-CH), 4.11(m, 1H, 9-CH), 2.35(t, 2H, 2-CH_2 ), 0.89(m, 3H, 20-CH_3 ) [[Reference:Kotovych_G:Aarts_GHM:,Can. J. Chem.,1980,58,1111\|{{RelationTable/GetFirstAuthor\|Reference:Kotovych_G:Aarts_GHM:,Can. J. Chem.,1980,58,1111}}]]
	\|Source=Thromboxane B2 as a stable degradation product of bioactive but unstable thromboxane A2 is detected in the tissue where thromboxane A2 is produced [[Reference:Moncada_S:Vane_JR:,Pharmacol. Rev.,1978,30,293\|{{RelationTable/GetFirstAuthor\|Reference:Moncada_S:Vane_JR:,Pharmacol. Rev.,1978,30,293}}]].		\|Source=Thromboxane B2 as a stable degradation product of bioactive but unstable thromboxane A2 is detected in the tissue where thromboxane A2 is produced [[Reference:Moncada_S:Vane_JR:,Pharmacol. Rev.,1978,30,293\|{{RelationTable/GetFirstAuthor\|Reference:Moncada_S:Vane_JR:,Pharmacol. Rev.,1978,30,293}}]].

Editor: LBF20307TX02 moved to LBF20207TX02

2010-02-19T14:00:10Z

LBF20307TX02 moved to LBF20207TX02

← Older revision		Revision as of 23:00, 19 February 2010
Line 9:		Line 9:
	\|Common Name=&&THROMBOXANE B2&&7- [ Tetrahydro-4 (S) ,6-dihydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -2H-pyran-3 (S) -yl ] -5 (Z) -heptenoic acid&&		\|Common Name=&&THROMBOXANE B2&&7- [ Tetrahydro-4 (S) ,6-dihydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -2H-pyran-3 (S) -yl ] -5 (Z) -heptenoic acid&&
	\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|Optical=[alpha]X^25_D =57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Optical=[ alpha ]X^25_D =57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|Solubility=ETHYL ACETATE		\|Solubility=ETHYL ACETATE
	\|Mass Spectra=m/e 335, 317 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Mass Spectra=m/e 335, 317 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|IR Spectra=FILM: nu 3380, 1705cm^- ^1 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|IR Spectra=FILM: nu 3380, 1705cm^- ^1 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|NMR Spectra=^1 H-NMR(CDCl_3 ) : delta 5.86(m, 1H, 14-CH), 5.72(m, 1H, 13-CH), 5.46(m, 2H, 5,6-CH), 5.35 and 5.23(m, 1H, 11-CH), 4.41(m, 1H, 12-CH), 4.22(m, 1H, 15-CH), 4.11(m, 1H, 9-CH), 2.35(t, 2H, 2-CH_2 ), 0.89(m, 3H, 20-CH_3 ) [[Reference:Kotovych_G:Aarts_GHM:,Can. J. Chem.,1980,58,1111\|{{RelationTable/GetFirstAuthor\|Reference:Kotovych_G:Aarts_GHM:,Can. J. Chem.,1980,58,1111}}]]		\|NMR Spectra=^1 H-NMR(CDCl_3 ) : delta 5.86(m, 1H, 14-CH), 5.72(m, 1H, 13-CH), 5.46(m, 2H, 5,6-CH), 5.35 and 5.23(m, 1H, 11-CH), 4.41(m, 1H, 12-CH), 4.22(m, 1H, 15-CH), 4.11(m, 1H, 9-CH), 2.35(t, 2H, 2-CH_2 ), 0.89(m, 3H, 20-CH_3 ) [[Reference:Kotovych_G:Aarts_GHM:,Can. J. Chem.,1980,58,1111\|{{RelationTable/GetFirstAuthor\|Reference:Kotovych_G:Aarts_GHM:,Can. J. Chem.,1980,58,1111}}]]
	\|Source=Thromboxane B2 as a stable degradation product of bioactive but unstable thromboxane A2 is detected in the tissue where thromboxane A2 is produced [[Reference:Moncada_S:Vane_JR:,Pharmacol. Rev.,1978,30,293\|{{RelationTable/GetFirstAuthor\|Reference:Moncada_S:Vane_JR:,Pharmacol. Rev.,1978,30,293}}]].		\|Source=Thromboxane B2 as a stable degradation product of bioactive but unstable thromboxane A2 is detected in the tissue where thromboxane A2 is produced [[Reference:Moncada_S:Vane_JR:,Pharmacol. Rev.,1978,30,293\|{{RelationTable/GetFirstAuthor\|Reference:Moncada_S:Vane_JR:,Pharmacol. Rev.,1978,30,293}}]].
	\|Chemical Synthesis=[[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]] {{Image200\|LBF20207TX02FT0001.gif}}		\|Chemical Synthesis=[[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]] {{Image200\|LBF20207TX02FT0001.gif}}

Editor: LBF20307TX02 moved to LBF20207TX02

2010-02-19T14:00:00Z

LBF20307TX02 moved to LBF20207TX02

← Older revision		Revision as of 23:00, 19 February 2010
Line 9:		Line 9:
	\|Common Name=&&THROMBOXANE B2&&7- [ Tetrahydro-4 (S) ,6-dihydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -2H-pyran-3 (S) -yl ] -5 (Z) -heptenoic acid&&		\|Common Name=&&THROMBOXANE B2&&7- [ Tetrahydro-4 (S) ,6-dihydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -2H-pyran-3 (S) -yl ] -5 (Z) -heptenoic acid&&
	\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|Optical=[~~<FONT FACE="Symbol">a</FONT>~~]X~~<sub>D</sub><sup>25</sup>~~=57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Optical=[alpha]X^25_D =57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|Solubility=ETHYL ACETATE		\|Solubility=ETHYL ACETATE
	\|Mass Spectra=m/e 335, 317 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Mass Spectra=m/e 335, 317 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|IR Spectra=FILM: ~~<FONT FACE="Symbol">n</FONT>~~ 3380, 1705cm~~<SUP><FONT SIZE=-1>-</FONT></SUP><SUP><FONT SIZE=~~-1~~>1</FONT></SUP>~~ [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|IR Spectra=FILM: nu 3380, 1705cm^- ^1 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|NMR Spectra=~~<SUP><FONT SIZE=-~~1~~>1</FONT></SUP>~~H-NMR(~~CDCl<SUB><FONT SIZE=-1>3</FONT></SUB>~~) : ~~<FONT FACE="Symbol">d</FONT>~~ 5.86(m, 1H, 14-CH), 5.72(m, 1H, 13-CH), 5.46(m, 2H, 5,6-CH), 5.35 and 5.23(m, 1H, 11-CH), 4.41(m, 1H, 12-CH), 4.22(m, 1H, 15-CH), 4.11(m, 1H, 9-CH), 2.35(t, 2H, 2-~~CH<SUB><FONT SIZE=-1>2</FONT></SUB>~~), 0.89(m, 3H, 20-~~CH<SUB><FONT SIZE=-1>3</FONT></SUB>~~) [[Reference:Kotovych_G:Aarts_GHM:,Can. J. Chem.,1980,58,1111\|{{RelationTable/GetFirstAuthor\|Reference:Kotovych_G:Aarts_GHM:,Can. J. Chem.,1980,58,1111}}]]		\|NMR Spectra=^1 H-NMR(CDCl_3 ) : delta 5.86(m, 1H, 14-CH), 5.72(m, 1H, 13-CH), 5.46(m, 2H, 5,6-CH), 5.35 and 5.23(m, 1H, 11-CH), 4.41(m, 1H, 12-CH), 4.22(m, 1H, 15-CH), 4.11(m, 1H, 9-CH), 2.35(t, 2H, 2-CH_2 ), 0.89(m, 3H, 20-CH_3 ) [[Reference:Kotovych_G:Aarts_GHM:,Can. J. Chem.,1980,58,1111\|{{RelationTable/GetFirstAuthor\|Reference:Kotovych_G:Aarts_GHM:,Can. J. Chem.,1980,58,1111}}]]
	\|Source=Thromboxane B2 as a stable degradation product of bioactive but unstable thromboxane A2 is detected in the tissue where thromboxane A2 is produced [[Reference:Moncada_S:Vane_JR:,Pharmacol. Rev.,1978,30,293\|{{RelationTable/GetFirstAuthor\|Reference:Moncada_S:Vane_JR:,Pharmacol. Rev.,1978,30,293}}]].		\|Source=Thromboxane B2 as a stable degradation product of bioactive but unstable thromboxane A2 is detected in the tissue where thromboxane A2 is produced [[Reference:Moncada_S:Vane_JR:,Pharmacol. Rev.,1978,30,293\|{{RelationTable/GetFirstAuthor\|Reference:Moncada_S:Vane_JR:,Pharmacol. Rev.,1978,30,293}}]].
	\|Chemical Synthesis=[[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]] {{Image200\|LBF20207TX02FT0001.gif}}		\|Chemical Synthesis=[[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]] {{Image200\|LBF20207TX02FT0001.gif}}

Editor: LBF20307TX02 moved to LBF20207TX02

2010-01-06T21:00:00Z

LBF20307TX02 moved to LBF20207TX02

← Older revision		Revision as of 06:00, 7 January 2010
Line 9:		Line 9:
	\|Common Name=&&THROMBOXANE B2&&7- [ Tetrahydro-4 (S) ,6-dihydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -2H-pyran-3 (S) -yl ] -5 (Z) -heptenoic acid&&		\|Common Name=&&THROMBOXANE B2&&7- [ Tetrahydro-4 (S) ,6-dihydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -2H-pyran-3 (S) -yl ] -5 (Z) -heptenoic acid&&
	\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|~~Reflactive~~=[<FONT FACE="Symbol">a</FONT>]X<sub>D</sub><sup>25</sup>=57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Optical=[<FONT FACE="Symbol">a</FONT>]X<sub>D</sub><sup>25</sup>=57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|Solubility=ETHYL ACETATE		\|Solubility=ETHYL ACETATE
	\|Mass Spectra=m/e 335, 317 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Mass Spectra=m/e 335, 317 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
Line 17:		Line 17:
	\|Chemical Synthesis=[[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]] {{Image200\|LBF20207TX02FT0001.gif}}		\|Chemical Synthesis=[[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]] {{Image200\|LBF20207TX02FT0001.gif}}
	\|Metabolism=The major urinary metabolite of tromboxane B2 is 2,3-dinor-thromboxane B2 [[Reference:Kindahl_H:,Prostaglandins,1977,13,619\|{{RelationTable/GetFirstAuthor\|Reference:Kindahl_H:,Prostaglandins,1977,13,619}}]], and 11-dehydro-thromboxane B2 is known as a suitble parameter for monitoring thromboxane production in human [[Reference:Westlund_P:Granstrom_E:Kumlin_M:Nordenstrom_A:,Prostaglandins,1986,31,929\|{{RelationTable/GetFirstAuthor\|Reference:Westlund_P:Granstrom_E:Kumlin_M:Nordenstrom_A:,Prostaglandins,1986,31,929}}]]. 11-Hydroxythromboxane B2 dehydrogenase responsible for the 11-dehydro-thromboxane B2 production was identified as cytosolic aldehyde dehydrogenase [[Reference:Westlund_P:Fylling_AC:Cederlund_E:Jornvall_H:,FEBS Lett.,1994,345,99\|{{RelationTable/GetFirstAuthor\|Reference:Westlund_P:Fylling_AC:Cederlund_E:Jornvall_H:,FEBS Lett.,1994,345,99}}]].		\|Metabolism=The major urinary metabolite of tromboxane B2 is 2,3-dinor-thromboxane B2 [[Reference:Kindahl_H:,Prostaglandins,1977,13,619\|{{RelationTable/GetFirstAuthor\|Reference:Kindahl_H:,Prostaglandins,1977,13,619}}]], and 11-dehydro-thromboxane B2 is known as a suitble parameter for monitoring thromboxane production in human [[Reference:Westlund_P:Granstrom_E:Kumlin_M:Nordenstrom_A:,Prostaglandins,1986,31,929\|{{RelationTable/GetFirstAuthor\|Reference:Westlund_P:Granstrom_E:Kumlin_M:Nordenstrom_A:,Prostaglandins,1986,31,929}}]]. 11-Hydroxythromboxane B2 dehydrogenase responsible for the 11-dehydro-thromboxane B2 production was identified as cytosolic aldehyde dehydrogenase [[Reference:Westlund_P:Fylling_AC:Cederlund_E:Jornvall_H:,FEBS Lett.,1994,345,99\|{{RelationTable/GetFirstAuthor\|Reference:Westlund_P:Fylling_AC:Cederlund_E:Jornvall_H:,FEBS Lett.,1994,345,99}}]].
			\|Symbol=TXB2
			\|Biological Activity=Thromboxane B2 as s stable degradation product of thromboxane A2 shows diminishd biological activity [[Reference:Whittle_BJ:Moncada_S:,Br. Med. Bull.,1983,39,232\|{{RelationTable/GetFirstAuthor\|Reference:Whittle_BJ:Moncada_S:,Br. Med. Bull.,1983,39,232}}]].
	}}		}}

	{{Lipid/Footer}}		{{Lipid/Footer}}

← Older revision		Revision as of 11:02, 8 September 2010
Line 9:		Line 9:
	\|Common Name=&&THROMBOXANE B2&&		\|Common Name=&&THROMBOXANE B2&&
	\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|Optical=[ alpha ]X^{25}_D =57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Optical=[ alpha ]^{25}_D =57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|Solubility=ETHYL ACETATE [[Reference:Kelly RW:Schletter_I:Stein_SJ:,Tetrahedron_Lett.,1976,,3279\|{{RelationTable/GetFirstAuthor\|Reference:Kelly RW:Schletter_I:Stein_SJ:,Tetrahedron_Lett.,1976,,3279}}]]		\|Solubility=ETHYL ACETATE [[Reference:Kelly RW:Schletter_I:Stein_SJ:,Tetrahedron_Lett.,1976,,3279\|{{RelationTable/GetFirstAuthor\|Reference:Kelly RW:Schletter_I:Stein_SJ:,Tetrahedron_Lett.,1976,,3279}}]]
	\|Mass Spectra=m/e 335, 317 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Mass Spectra=m/e 335, 317 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]

← Older revision		Revision as of 18:14, 9 June 2010
Line 10:		Line 10:
	\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|Optical=[ alpha ]X^{25}_D =57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Optical=[ alpha ]X^{25}_D =57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|Solubility=ETHYL ACETATE [[Reference:Kelly RW:Schletter_I:Stein_SJ:,Tetrahedron_Lett.,1976,,3279\|{{RelationTable/GetFirstAuthor\|~~RReference~~:Kelly RW:Schletter_I:Stein_SJ:,Tetrahedron_Lett.,1976,,3279}}]]		\|Solubility=ETHYL ACETATE [[Reference:Kelly RW:Schletter_I:Stein_SJ:,Tetrahedron_Lett.,1976,,3279\|{{RelationTable/GetFirstAuthor\|Reference:Kelly RW:Schletter_I:Stein_SJ:,Tetrahedron_Lett.,1976,,3279}}]]
	\|Mass Spectra=m/e 335, 317 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Mass Spectra=m/e 335, 317 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|IR Spectra=FILM: nu 3380, 1705cm^{-1} [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|IR Spectra=FILM: nu 3380, 1705cm^{-1} [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]

← Older revision		Revision as of 18:14, 9 June 2010
Line 10:		Line 10:
	\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|Optical=[ alpha ]X^{25}_D =57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Optical=[ alpha ]X^{25}_D =57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|Solubility=ETHYL ACETATE		\|Solubility=ETHYL ACETATE [[Reference:Kelly RW:Schletter_I:Stein_SJ:,Tetrahedron_Lett.,1976,,3279\|{{RelationTable/GetFirstAuthor\|RReference:Kelly RW:Schletter_I:Stein_SJ:,Tetrahedron_Lett.,1976,,3279}}]]
	\|Mass Spectra=m/e 335, 317 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Mass Spectra=m/e 335, 317 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|IR Spectra=FILM: nu 3380, 1705cm^{-1} [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|IR Spectra=FILM: nu 3380, 1705cm^{-1} [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]

← Older revision		Revision as of 19:00, 25 February 2010
Line 9:		Line 9:
	\|Common Name=&&THROMBOXANE B2&&7- [ Tetrahydro-4 (S) ,6-dihydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -2H-pyran-3 (S) -yl ] -5 (Z) -heptenoic acid&&		\|Common Name=&&THROMBOXANE B2&&7- [ Tetrahydro-4 (S) ,6-dihydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -2H-pyran-3 (S) -yl ] -5 (Z) -heptenoic acid&&
	\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|Optical=[ alpha ]X^~~25_D~~ =57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Optical=[ alpha ]X^{25}_D =57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|Solubility=ETHYL ACETATE		\|Solubility=ETHYL ACETATE
	\|Mass Spectra=m/e 335, 317 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Mass Spectra=m/e 335, 317 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|IR Spectra=FILM: nu 3380, 1705cm^- ^1 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|IR Spectra=FILM: nu 3380, 1705cm^{-1} [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|NMR Spectra=^1 H-NMR(CDCl_3 ) : delta 5.86(m, 1H, 14-CH), 5.72(m, 1H, 13-CH), 5.46(m, 2H, 5,6-CH), 5.35 and 5.23(m, 1H, 11-CH), 4.41(m, 1H, 12-CH), 4.22(m, 1H, 15-CH), 4.11(m, 1H, 9-CH), 2.35(t, 2H, 2-CH_2 ), 0.89(m, 3H, 20-CH_3 ) [[Reference:Kotovych_G:Aarts_GHM:,Can. J. Chem.,1980,58,1111\|{{RelationTable/GetFirstAuthor\|Reference:Kotovych_G:Aarts_GHM:,Can. J. Chem.,1980,58,1111}}]]		\|NMR Spectra=^1 H-NMR(CDCl_3 ) : delta 5.86(m, 1H, 14-CH), 5.72(m, 1H, 13-CH), 5.46(m, 2H, 5,6-CH), 5.35 and 5.23(m, 1H, 11-CH), 4.41(m, 1H, 12-CH), 4.22(m, 1H, 15-CH), 4.11(m, 1H, 9-CH), 2.35(t, 2H, 2-CH_2 ), 0.89(m, 3H, 20-CH_3 ) [[Reference:Kotovych_G:Aarts_GHM:,Can. J. Chem.,1980,58,1111\|{{RelationTable/GetFirstAuthor\|Reference:Kotovych_G:Aarts_GHM:,Can. J. Chem.,1980,58,1111}}]]
	\|Source=Thromboxane B2 as a stable degradation product of bioactive but unstable thromboxane A2 is detected in the tissue where thromboxane A2 is produced [[Reference:Moncada_S:Vane_JR:,Pharmacol. Rev.,1978,30,293\|{{RelationTable/GetFirstAuthor\|Reference:Moncada_S:Vane_JR:,Pharmacol. Rev.,1978,30,293}}]].		\|Source=Thromboxane B2 as a stable degradation product of bioactive but unstable thromboxane A2 is detected in the tissue where thromboxane A2 is produced [[Reference:Moncada_S:Vane_JR:,Pharmacol. Rev.,1978,30,293\|{{RelationTable/GetFirstAuthor\|Reference:Moncada_S:Vane_JR:,Pharmacol. Rev.,1978,30,293}}]].

← Older revision		Revision as of 23:00, 19 February 2010
Line 9:		Line 9:
	\|Common Name=&&THROMBOXANE B2&&7- [ Tetrahydro-4 (S) ,6-dihydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -2H-pyran-3 (S) -yl ] -5 (Z) -heptenoic acid&&		\|Common Name=&&THROMBOXANE B2&&7- [ Tetrahydro-4 (S) ,6-dihydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -2H-pyran-3 (S) -yl ] -5 (Z) -heptenoic acid&&
	\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Melting Point=95-96°C [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|Optical=[alpha]X^25_D =57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Optical=[ alpha ]X^25_D =57.4°(C=0.26 ETHYL ACETATE) [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|Solubility=ETHYL ACETATE		\|Solubility=ETHYL ACETATE
	\|Mass Spectra=m/e 335, 317 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|Mass Spectra=m/e 335, 317 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|IR Spectra=FILM: nu 3380, 1705cm^- ^1 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]		\|IR Spectra=FILM: nu 3380, 1705cm^- ^1 [[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]]
	\|NMR Spectra=^1 H-NMR(CDCl_3 ) : delta 5.86(m, 1H, 14-CH), 5.72(m, 1H, 13-CH), 5.46(m, 2H, 5,6-CH), 5.35 and 5.23(m, 1H, 11-CH), 4.41(m, 1H, 12-CH), 4.22(m, 1H, 15-CH), 4.11(m, 1H, 9-CH), 2.35(t, 2H, 2-CH_2 ), 0.89(m, 3H, 20-CH_3 ) [[Reference:Kotovych_G:Aarts_GHM:,Can. J. Chem.,1980,58,1111\|{{RelationTable/GetFirstAuthor\|Reference:Kotovych_G:Aarts_GHM:,Can. J. Chem.,1980,58,1111}}]]		\|NMR Spectra=^1 H-NMR(CDCl_3 ) : delta 5.86(m, 1H, 14-CH), 5.72(m, 1H, 13-CH), 5.46(m, 2H, 5,6-CH), 5.35 and 5.23(m, 1H, 11-CH), 4.41(m, 1H, 12-CH), 4.22(m, 1H, 15-CH), 4.11(m, 1H, 9-CH), 2.35(t, 2H, 2-CH_2 ), 0.89(m, 3H, 20-CH_3 ) [[Reference:Kotovych_G:Aarts_GHM:,Can. J. Chem.,1980,58,1111\|{{RelationTable/GetFirstAuthor\|Reference:Kotovych_G:Aarts_GHM:,Can. J. Chem.,1980,58,1111}}]]
	\|Source=Thromboxane B2 as a stable degradation product of bioactive but unstable thromboxane A2 is detected in the tissue where thromboxane A2 is produced [[Reference:Moncada_S:Vane_JR:,Pharmacol. Rev.,1978,30,293\|{{RelationTable/GetFirstAuthor\|Reference:Moncada_S:Vane_JR:,Pharmacol. Rev.,1978,30,293}}]].		\|Source=Thromboxane B2 as a stable degradation product of bioactive but unstable thromboxane A2 is detected in the tissue where thromboxane A2 is produced [[Reference:Moncada_S:Vane_JR:,Pharmacol. Rev.,1978,30,293\|{{RelationTable/GetFirstAuthor\|Reference:Moncada_S:Vane_JR:,Pharmacol. Rev.,1978,30,293}}]].
	\|Chemical Synthesis=[[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]] {{Image200\|LBF20207TX02FT0001.gif}}		\|Chemical Synthesis=[[Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562\|{{RelationTable/GetFirstAuthor\|Reference:Hanessian_S:Lavallee_P:,Can. J. Chem.,1977,55,562}}]] {{Image200\|LBF20207TX02FT0001.gif}}